Functional activity in vivo of effector T cell populations. I. Antitumor activity exhibited by allogeneic mixed leukocyte culture cells
- PMID: 6213710
Functional activity in vivo of effector T cell populations. I. Antitumor activity exhibited by allogeneic mixed leukocyte culture cells
Abstract
The in vivo activity of murine cytolytic T lymphocyte-containing effector cell populations generated in vitro was studied in a tumor allograft model system by monitoring the elimination of 131I-IUdR-labeled tumor cells with whole-body counting techniques. Mice were irradiated sublethally and 16 hr later 131I-labeled tumor cells were injected either subcutaneously or i.p. Simultaneously, graded doses of various effector cell populations were injected i.v. and the mice were counted daily to assess the potential elimination of the radiolabeled tumor cells. Thus, allogeneic 2 degrees mixed leukocyte culture cells were observed to eliminate allogeneic but not syngeneic tumor cells in a dose-dependent manner, with as few as 0.2 x 10(6) effector cells causing significant destruction of 2 x 10(6) allogeneic tumor cells. The protective effect of the mixed leukocyte culture cells was considerably reduced when Lyt-2+-bearing lymphocytes were eliminated by treatment with monoclonal antibody plus complement. In additional experiments, Lyt-2+ lymphocytes positively selected by enrichment on antibody-coated petri dishes gave efficient protection, in the absence of Lyt-2- cells. Surprisingly, when several different cloned, specific, long-term allogeneic cytolytic T cells lines were injected either i.p. of i.v., tumor cell destruction was observed only after i.p. injection.
Similar articles
-
Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.J Immunol. 1984 Sep;133(3):1664-70. J Immunol. 1984. PMID: 6205090
-
Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.Eur J Immunol. 1987 Feb;17(2):173-8. doi: 10.1002/eji.1830170204. Eur J Immunol. 1987. PMID: 3030766
-
LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.J Immunol. 1983 Aug;131(2):1017-23. J Immunol. 1983. PMID: 6223084
-
Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells.Cancer Res. 1981 Feb;41(2):383-98. Cancer Res. 1981. PMID: 6160907
-
Virus-lymphocyte interactions.Arthritis Rheum. 1978 Jun;21(5 Suppl):S17-26. doi: 10.1002/art.1780210904. Arthritis Rheum. 1978. PMID: 27197 Review. No abstract available.
Cited by
-
Modulation of the immune response by gangliosides. Inhibition of adherent monocyte accessory function in vitro.J Clin Invest. 1984 Dec;74(6):2074-81. doi: 10.1172/JCI111631. J Clin Invest. 1984. PMID: 6511916 Free PMC article.
-
The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients.Cancer Immunol Immunother. 1984;18(2):69-74. doi: 10.1007/BF00205736. Cancer Immunol Immunother. 1984. PMID: 6334549 Free PMC article.
-
Human T cell clones express functional homing receptors required for normal lymphocyte trafficking.J Exp Med. 1985 Sep 1;162(3):1075-80. doi: 10.1084/jem.162.3.1075. J Exp Med. 1985. PMID: 3875680 Free PMC article.
-
Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.J Exp Med. 1984 Feb 1;159(2):495-507. doi: 10.1084/jem.159.2.495. J Exp Med. 1984. PMID: 6141211 Free PMC article.
-
Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1.Immunology. 1985 Sep;56(1):127-40. Immunology. 1985. PMID: 3876271 Free PMC article.